On this page you will find all of ACB’s publications. To the right are the search categories that will help you navigate around the ACB’s extensive work.
More poisoning of South Africa’s staple food given the go-ahead: 2,4-D GM maize varieties approved
The African Centre for Biodiversity (ACB) is extremely alarmed to learn that three genetically modified maize varieties developed by Corteva (new name of the Dow-DuPont merged entity) to withstand the application of the dangerous 2,4-D herbicide have been approved for general release by the Executiv
Resounding no to Monsanto’s ‘bogus’ GM drought tolerant maize
Resounding no to Monsanto’s ‘bogus’ GM drought tolerant maize: South Africa’s Minister, Appeal Board and Biosafety Authority Reject Monsanto’s GM seeds
Johannesburg, South Africa, 4 October 2019
AFRICANS REFUSE TO BE CHEMICAL DUMPING GROUND
Civil society organisations and citizens across Africa are calling upon their governments to issue an immediate ban on all use of glyphosate and glyphosate-based herbicides (GBHs).
Civil Society Denounces the Release of GM mosquitoes in Burkina Faso
We, the undersigned civil society organisations from Africa and around the world, denounce the release of genetically modified (GM) “male-sterile” mosquitoes in Burkina Faso. The GM mosquitoes were released in the village of Bana on 1 July 2019 by the Target Malaria research consortium.[i]
South Africa’s new seed and PVP Acts undermine farmers’ rights and entrench corporate capture, control and domination
Press Release from the African Centre for Biodiversity (ACB)
23 April 2019, Johannesburg, South Africa
Objection against general release of three 2,4-D GM maize varieties
South Africa targeted for testing of risky new gene silencing technology for benefit of corporate maize seed producers
The African Centre for Biodiversity (ACB) has lodged an objection against Pioneer Hi-Bred’s application for field trials of RNAi /gene silencing (DP-566113-9) GM maize, since the risks to the health of the environment and humans is, as yet, unknown.
Mark Lynas slammed for exploiting African farmers’ images to promote GMOs
African farmers are demanding that Lynas cease using their images in his GMO promotionals; Lynas’s mischief-making may have triggered Tanzania’s ending of GMO field trials. Report: Claire Robinson, GMWatch and Mariam Mayet, African Centre for Biodiversity
SA Government rejects Monsanto’s Triple stacked GM Drought tolerant maize
PRESS RELEASE from the African Centre for Biodiversity
SA Government rejects Monsanto’s Triple stacked GM Drought tolerant maize
Johannesburg 15 November 2018
Release of risky GM mosquitoes in Burkina Faso highly unethical
Press Release issued by African Centre for Biodiversity, Third World Network and GeneWatch UK
Johannesburg, 9 November 2018
Release of risky GM mosquitoes in Burkina Faso highly unethical
AU’s premature and misguided endorsement of controversial, unproven gene drive mosquitos for malaria ‘eradication’ in Africa
Press Release from the African Centre for Biodiversity
AU’s premature and misguided endorsement of controversial, unproven gene drive mosquitos for malaria ‘eradication’ in Africa
Johannesburg, Monday, 5 November 2018
Media release: Civil society responds to BioAfrica Convention
For immediate release 28 August 2018
BioAfrica Convention: Open for the business of profit; closed to the questions that matter
WEMA’S Bt Maize & Fall Armyworm Africa claims are unscientific and unsubstantiated
Press Release from the African Centre for Biodiversity
Johannesburg, June 27
Parliamentary consultation & decision making on SA’s Corporate Seed Bills a Sham!!
The African Centre for Biodiversity (ACB) is deeply concerned that South Africa’s draconian corporate seed Bills were approved by the Parliamentary Select Committee on the 22nd May 2018, with no substantial changes being made.
Press Release: No benefit to imminent release of risky GM mosquitoes in Burkina Faso
Genetically modified (GM) “male-sterile” mosquitoes are due to be released in Burkina Faso this year by the Target Malaria research consortium. However, Target Malaria acknowledges that there are no benefits to the proposed GM mosquito release.